Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5499)
All Articles published online
|
Apr 7, 2006 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kojima H, Sakurai S, Matsumura M, Umemoto N, Uemura M, Morimoto H, Tamagawa Y, Fukui H. Cryptogenic cirrhosis in the region where obesity is not prevalent. World J Gastroenterol 2006; 12(13): 2080-2085 [PMID: 16610061 DOI: 10.3748/wjg.v12.i13.2080] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i13/2080.htm |
| Number | Citing Articles |
| 1 |
Eduardo Fassio, Fernando J Barreyro, M Soledad Pérez, Diana Dávila, Graciela Landeira, Gisela Gualano, Gabriela Ruffillo. Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?. World Journal of Hepatology 2022; 14(2): 354-371 doi: 10.4254/wjh.v14.i2.354
|
| 2 |
Shivakumar Chitturi, Geoffrey C Farrell, Etsuko Hashimoto, Toshiji Saibara, George KK Lau, José D Sollano. Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines. Journal of Gastroenterology and Hepatology 2007; 22(6): 778 doi: 10.1111/j.1440-1746.2007.05001.x
|
| 3 |
Sahil Mittal, Donna L. White, Fasiha Kanwal, Norman Sussman, Hashem B. El-Serag. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma: How Common?. Current Hepatology Reports 2015; 14(2): 87 doi: 10.1007/s11901-015-0259-5
|
| 4 |
Jorge-Shmuel Delgado. Evolving trends in nonalcoholic fatty liver disease. European Journal of Internal Medicine 2008; 19(2): 75 doi: 10.1016/j.ejim.2007.02.034
|
| 5 |
Stephen Caldwell. Cryptogenic Cirrhosis: What Are We Missing?. Current Gastroenterology Reports 2010; 12(1): 40 doi: 10.1007/s11894-009-0082-7
|
| 6 |
Cyrielle Caussy. Should We Screen High-Risk Populations for NAFLD?. Current Hepatology Reports 2019; 18(4): 433 doi: 10.1007/s11901-019-00497-7
|
| 7 |
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 2020; 14(6): 889 doi: 10.1007/s12072-020-10094-2
|
| 8 |
Sudul Mananjala Senanayake, Madunil Anuk Niriella, Sanjaya Kumara Weerasinghe, Anuradhani Kasturiratne, Jerome Praneeth de Alwis, Arjuna Priyadarsin de Silva, Anuradha Supun Dassanayake, Hithanadura Janaka de Silva. Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study. BMC Research Notes 2012; 5(1) doi: 10.1186/1756-0500-5-663
|
| 9 |
Matthew D. Merrell, Nathan J. Cherrington. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metabolism Reviews 2011; 43(3): 317 doi: 10.3109/03602532.2011.577781
|
| 10 |
Roslyn Vongsuvanh, David van der Poorten, Jacob George. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific. Hepatology International 2013; 7(S2): 823 doi: 10.1007/s12072-013-9453-0
|
| 11 |
Mitchell S. Wachtel, Yan Zhang, Kim E. Kaye, Maurizio Chiriva-Internati, Eldo E. Frezza. Increased Age, Male Gender, and Cirrhosis, but Not Steatosis or a Positive Viral Serology, Negatively Impact the Life Expectancy of Patients who Undergo Liver Biopsy. Digestive Diseases and Sciences 2007; 52(9): 2276 doi: 10.1007/s10620-006-9715-y
|
| 12 |
Don C. Rockey, Stephen H. Caldwell, Zachary D. Goodman, Rendon C. Nelson, Alastair D. Smith. Liver biopsy. Hepatology 2009; 49(3): 1017 doi: 10.1002/hep.22742
|
| 13 |
Curtis K. Argo, Stephen H. Caldwell. Epidemiology and Natural History of Non-Alcoholic Steatohepatitis. Clinics in Liver Disease 2009; 13(4): 511 doi: 10.1016/j.cld.2009.07.005
|
| 14 |
Ilke Nalbantoglu, Dhanpat Jain. Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine. Seminars in Diagnostic Pathology 2019; 36(6): 389 doi: 10.1053/j.semdp.2019.07.003
|
| 15 |
Sui‐Weng Wong, Yi‐Wen Ting, Wah‐Kheong Chan. Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications. JGH Open 2018; 2(5): 235 doi: 10.1002/jgh3.12070
|
| 16 |
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim. Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome. The Korean Journal of Internal Medicine 2012; 27(1): 47 doi: 10.3904/kjim.2012.27.1.47
|
| 17 |
Chandrashekaraiah Bharath Kumar, Ashish Goel, Rajeeb Jaleel, Deepu David, Uday Zachariah, Jeyamani Ramachandran, Chundamannil E. Eapen. Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(2): 492 doi: 10.1016/j.jceh.2021.05.008
|
| 18 |
Shail Maheshwari, Amrou Sarraj, Jennifer Kramer, Hashem B. El-Serag. Oral contraception and the risk of hepatocellular carcinoma. Journal of Hepatology 2007; 47(4): 506 doi: 10.1016/j.jhep.2007.03.015
|
| 19 |
Makoto Ohbu. Clinical Investigation of Portal Hypertension. 2019; : 3 doi: 10.1007/978-981-10-7425-7_1
|
| 20 |
Nabeen C. Nayak, Nandini Vasdev, Sanjiv Saigal, Arvinder S. Soin. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Human Pathology 2010; 41(3): 425 doi: 10.1016/j.humpath.2009.06.021
|
| 21 |
Sahil Mittal, Hashem B. El-Serag. Epidemiology of Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2013; 47(Supplement 1): S2 doi: 10.1097/MCG.0b013e3182872f29
|
| 22 |
Fabio Nascimbeni, Vlad Ratziu. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 271 doi: 10.1007/978-3-319-20538-0_14
|
| 23 |
Luca Rinaldi, Fabio Nascimbeni, Mauro Giordano, Chiara Masetti, Barbara Guerrera, Annalisa Amelia, Maria Chiara Fascione, Stefano Ballestri, Dante Romagnoli, Rosa Zampino, Riccardo Nevola, Enrica Baldelli, Natalina Iuliano, Valerio Rosato, Amedeo Lonardo, Luigi Elio Adinolfi. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World Journal of Gastroenterology 2017; 23(8): 1458-1468 doi: 10.3748/wjg.v23.i8.1458
|
| 24 |
Donna L. White, Fasiha Kanwal, Hashem B. El–Serag. Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review. Clinical Gastroenterology and Hepatology 2012; 10(12): 1342 doi: 10.1016/j.cgh.2012.10.001
|